Resources to get started right

Receive guidance on co-pay assistance and reimbursement matters.

Learn more

Questions about cutaquig?

Find helpful answers to common questions about cutaquig and PI.

Learn more

References:
  1. Cutaquig® [package insert]. Lachen, Switzerland: Octapharma AG; 2019.
  2. Kobayashi RH, Gupta S, Melamed I, et al. Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies. Front Immunol. 2019;10(40):1-12.